Key Findings:
– Nearly 10% of pharmaceutical manufacturers are highly susceptible to a ransomware attack
– More than 12% of pharmaceutical industry vendors are likely to incur a ransomware attack
– Almost half of all pharmaceutical companies have more than 1,000 leaked employee credentials exposed on the deep web
– Pharmaceutical companies’ annual cyberattack risk averages $31.1 million
– Medium-sized pharmaceutical companies have the highest susceptibility to ransomware
– Data management vendors pose the most significant annual financial risk ($6.2 million) to pharmaceutical manufacturers
– Software vendors vary the most in terms of estimated financial risk, ranging from $331,000 to $46.1 million annually